Survival analysis revealed that FTO-high patients had significantly worse event-free survival (log-rank test, p = 0.047; Fig. 1D) and overall survival (log-rank test, p = 0.056; Additional file 1: Fig. S1A) than FTO-low patients with t(8;21) AML. This evidence concerns the gene FTO and acute myeloid leukemia.